18 results with keyword: 'prevention fibrillation angiotensin converting inhibitors angiotensin receptor blockers'
ACE-inhibitors: angiotensin-converting enzyme inhibitors; ADR: adverse drug reaction; ARB: angiotensin receptor blockers; AT2-antagonists: angiotensin II receptor antagonists;
N/A
Participants will have the opportunity to gain a wealth of new teaching ideas, practical classroom skills and CLIL materials for use in the primary classroom and also to
N/A
Calcium channel blockers, diuretics, angiotensin receptor blockers, beta-adrenergic blockers, and angiotensin converting enzyme inhibitors were consistently the most
N/A
ACEI/ARB — angiotensin converting enzyme inhibitors/angiotensin II receptor blockers; AF — atrial fibrillation; BMI — body mass index; BUN — blood urea nitrogen; E/e’ ratio —
N/A
Evidence shows that angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), aldosterone receptor antagonists and calcium channel blockers
N/A
Abbreviations: ACEIs, angiotensin-converting enzyme inhibitors; ARBs, angiotensin receptor blockers; BB, beta-blockers; BD, bipolar disorder; CCB, calcium channel blockers;
N/A
hemodialysis patients includes mainly angiotensin- converting enzyme (ACE) inhibitors, angiotensin II receptor blockers, beta-blockers and diuretics, but guidelines
N/A
OBJECTIVES This study was designed to identify all randomized clinical trial data evaluating angiotensin- converting enzyme inhibitors or angiotensin receptor blockers for
N/A
ACEIs: angiotensin-converting enzyme inhibitors; ARBs: angiotensin receptor blockers; BBs: beta blockers; BN: benign nephrosclerosis; CCBs: calcium channel blockers; CI:
N/A
Angiotensin converting enzyme inhibitors (ACE), angiotensin receptor blockers (ARB), beta blockers (BB), calcium channel blockers (CCB), or thiazide diuretics (THZ)...
N/A
ACE: Acarbose Cardiovascular Evaluation Trial; AHAs: anti-hyperglycaemic agents; ACE-inhibitors: angiotensin-converting enzyme inhibitors; ARBs: angiotensin-II receptor blockers;
N/A
ACEIs: Angiotensin-Converting Enzyme Inhibitors; ARBs: Angiotensin Receptor Blockers; BBs: Beta-Blockers; BCBV: Better Care Better Value; BNF: British National Formulary;
N/A
In this review, we discuss drug repurposing of approved cardiovascular drugs, such as aspirin, beta-blockers, angiotensin converting enzyme inhibitors, angiotensin II receptor
N/A
Abbreviations: ACeis, angiotensin converting enzyme inhibitors; ARBs, angiotensin receptor blockers; BNP, brain natriuretic peptide; CRT, cardiac resynchronization therapy; CT
N/A
ACEI: angiotensin-converting enzyme inhibitors; AHAs: anti-hyperglycemic agents; Ang II: angiotensin II; ARBs: angiotensin receptor blockers; BP: blood pressure; BUN: blood
N/A
Diuretics, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, direct renin inhibitors, NSAIDs, metformin and sulfonylureas in at-risk patients experiencing
N/A
ACEIs: Angiotensin-Converting Enzyme Inhibitors; ARBs: Angiotensin Receptor Blockers; BBs: Beta-Blockers; BCBV: Better Care Better Value; BNF: British National Formulary;
N/A
ACEIs: Angiotensin-Converting Enzyme Inhibitors; ARBs: Angiotensin Receptor Blockers; BBs: Beta-Blockers; BCBV: Better Care Better Value; BNF: British National Formulary;
N/A